Early HIV infection in vivo: Branching-process model for studying timing of immune responses and drug therapy

Mathematical Biosciences

Volumn 165, Issue 2, 2000, Pages 115-134

  Wick, David ^a   Self, Steven G ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Antiretroviral treatment; Branching process models; Early intervention; Extinction; HAART; In vivo kinetics; Pathogen eradication; PMPA; Primary HIV infection; Primary SIV infection

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; STOCHASTIC MODEL; VIRUS PATHOGENESIS;

ADENINE; ANIMALS; ANTI-HIV AGENTS; COMPUTER SIMULATION; DISEASE PROGRESSION; HIV; HIV INFECTIONS; HUMANS; MACACA; MACROPHAGES; MODELS, IMMUNOLOGICAL; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SOMAN; STOCHASTIC PROCESSES; TIME FACTORS; VIRAL LOAD;

EID: 0034048013     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(00)00013-4     Document Type: Article

References (68)

1. Kahn J.O., Walker B.D. Acute human immunodeficiency virus type 1 infection. NEJM. 339(1):1998;33.
2. Niu M.T., Stein D.S., Schnittman S.M. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in human and animal retroviral infections. J. Infect. Dis. 168:1993;1490.
3. Schrager L.K., D'Souza M.P. Cellular and anatomical reservoirs of HIV-1 in patients receving potent antiretroviral combination therapy. JAMA. 280(1):1998;67.
4. Busch M.P. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am. J. Med. 102(5b):1997;117.
5. + lymphocytes Science. 283:1999;857.
6. X. Jin, D.E. Bauer, S.E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C.E. Irwin, J.T. Safrit, J. Mittler, L. Weinberger, L.G. Kostrikis, L. Zhang, A.S. Perelson, D.D. Ho, Dramatic rise in plasma viremia after CD8(+) T-cell depletion in simian immunodeficiency virus-infected macaques, J. Exp. Med. Mar 15. 189 (6) (1999) 991.
7. Phillips A.N. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science. 271:1996;497.
8. De Boer R.J., Perelson A.S. Target-cell limited and immune control models of HIV infection: a comparison. J. Theor. Biol. 190(3):1998;201.
9. DeGrutolla V., Seage G.H., Mayer K.H., Horsburgh C.R. Jr. Infectiousness of HIV between male homosexual partners. J. Clin. Med. 42:1989;849.
10. Jewel N.P., Siboski S. Statistical analysis of HIV infectivity based on partner studies. Biometrics. 46:1990;1133.
11. mne infection depends critically on timing of initiation and duration of treatment J. Virol. 72:1998;4265.
12. + lymphocyte depletion in HIV infection Folia Biol (Praha). 35(3):1989;156.
13. Nowak M.A., May R.M. Mathematical biology of HIV infections: antigenic variation and diversity threshold. Math. Biosci. 106:1991;1.
14. M.A. Nowak, A.L. Lloyd, G.M. Vasquez et al., Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection, J. Virol. 71 (1997) 7518.
15. Turelli M. Random environments and stochastic calculus. Theor. Popul. Biol. 12:1977;140.
16. Jagers P. Branching Processes with Biological Applications. 1975;Wiley, New York.
17. Moolgavkar S., Venzon D. Two-event model for carcinogenesis: incidence curves for childhood and adult tumors. Math. Biosci. 47:1979;55.
18. Moolgavkar S., Luebeck G. Two-event model for carcinogenesis: biological, mathematical, and statistical considerations. Risk Anal. 10(2):1990;323.
19. Anderson R.M., May R.M. Infectious diseases of humans: dynamics and control. 1991;Oxford University, Oxford.
20. Mode C.J. Multitype Branching Processes: Theory and Applications. 1971;Elsevier, Amsterdam.
21. Zhu T., Mo H., Wang N., Cao Y., Koup R.A., Ho D.D. Genotypic and phenotypic characterization of human immunodeficiency virus type 1 in patients with primary infection. Science. 261:1993;1179.
22. Zhu T., Wang N., Carr A., Nam D.S., Moor-Jankowski R., Cooper D.A., Ho D.D. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization during sexual transmission. J. Virol. 70(5):1996;3098.
23. Blauvelt A. The role of skin dendritic cells in the initiation of human immunodeficiency virus infection. Am. J. Med. 102(5B):1997;16.
24. Schuitemaker H.M., Koot H.M., Kootstra N.A., Dercksen M.W., Goede R.E., van Steenwijk R.P., Lange J.M., Schattenkerk J.K., Miedema F., Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1992;1354.
25. van't Wout, Kootsra A.B.N.A., Mulder-Kampinga G.A., Albrecht-van Lent N., Scherpier H.J., Veenstra J., Boer K., Coutinho R.A., Miedema F., Schuitemaker H. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual parenteral and vertical transmission. J. Clin. Invest. 94:1994;2060.
26. Zaitseva M., Blauvelt A., Lee S., Lapham C.K., Klaus-Kovtun V., Mostowki H., Manischewitz J., Golding H. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for primary HIV infection. Nat. Med. 3:1997;1369.
27. G. Stent, G.B. Joo, P. Kierulf, B. Asjo, Macrophage tropism: fact or fiction? J. Leukoc. Biol. Jul. 62 (1) (1997) 4.
28. A. Haase, presentation at Fred Hutchinson CRC, Seattle, June 1999.
29. R. van Furth, H. Beekhoizen, Monocytes, in: Encyclopedia of Immunology, 2nd Ed., Academic Press, New York, 1998.
30. Atzpodien J., Dittmar K.E.J. Images in clinical medicine. New Eng. J. Med. 340:1999;1732.
31. J. McElrath, Seminar presentation, March 1999, University of Washington, Seattle.
32. Perelson A.S., Essunger P., Yunzhen C., Vesanen M., Hurley A., Saksela K., Markowitz M., Ho D.D. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature. 387:1997;188.
33. V. Finzi, M.H. Hermanlova, T. Pierson et al., Identification of a reservoir for HIV-1 patients on highly active antiretroviral therapy, Science 278 (1997) 1295.
34. van Furth R. Origin and turnover of monocytes and macrophages. Curr. Top. Pathol. 79:1989;125.
35. Zack J.A., Cann A.J., Lugo J.P., Chen I.S.Y. AIDS virus production from infected peripheral blood T-cells following HTLV-1 induced mitogenic stimulation. Science. 240:1988;1026.
36. Zagury D., Bernard J., Leonard R., Cheynier R., Feldman M., Sarin P.S., Gallo R.C. Long-term cultures of HTLV-III infected cells: a model of cytopathology of T-cell depletion in AIDS. Science. 231:1986;850.
37. Stevenson M., Gendelman H.E. Cellular and viral determinants that regulate HIV-1 infection in macrophages. J. Leukoc. Biol. 56:1994;278.
38. + T-lymphocytes in HIV-1 infection as measured by Ki-67 antigen J. Exp. Med. 187(8):1998;1295.
39. E.S. Razvi, R.R. Welsh, Apoptosis in viral infections, in: Advances in Viral Research, vol. 45, Academic Press, New York, 1995.
40. + T-cells in HIV infection: a case of over-stimulation? J. Theor. Biol. 197 (1999) 507.
41. Wick D. On T-cell dynamics and the hyperactivation theory of AIDS pathogenesis. Math. Biosci. 158:1999;127.
42. Igarashi T., Brown C., Azadegan A., Haigwood N., Dimitrov D., Martin M.A., Shibata R. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat. Med. 5(2):1999;211.
43. Weinberg J.B., Matthews T.J., Cullen B.R. Productive HIV-1 infection of non-proliferating human monocytes. J. Exp. Med. 174:1991;1477.
44. Tsai W.P., Conley S.R., Kung H.F., Garrity R.R., Nara P.L. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells. Virology. 226(2):1996;205.
45. Dimitrov D.S., Wiley R.L., Sato H., Chang L.J., Blumenthal R., Martin M.A. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67:1993;2182.
46. Kim S., Byrn R., Goopman J., Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63(9):1989;3708.
47. Pellegrino M.G., Li G., Potash M.J., Volsky D.J. Contribution of multiple rounds of viral entry and reverse transcription of expression to human immunodeficiency virus type 1. J. Biol. Chem. 266:1991;1783.
48. Aiken C., Konner J., Landau N.R., Lenburg M.E., Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76(5):1994;853.
49. J.H. Jandl (Ed.), Blood: Textbook of Hematology, Little Brown, New York, 1996, p. 54.
50. Mcllroy D., Autran B., Cheynier R., Clauvel J.P., Oksenhendler E., Debre P., Hosmalin A. Low infection frequencies of macrophages in the spleens of HIV-1. + patients Res. Virol. 147(2&3):1996;115.
51. McElrath M.J., Pruett J.E., Cohn Z.A. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Nat. Acad. Sci. USA. 86(2):1989;675.
52. Orenstein J.M., Fox C., Wahl S.M. Macrophages as a source of HIV during opportunistic infections. Science. 276:1997;1857.
53. H. Mutimer, PhD thesis, Monash University, 1998.
54. Lebowitz J.L., Rubinow S.I. A theory for the age and generation time distribution of a microbial population. J. Math. Biol. 1:1974;17.
55. Z. Grossman, M. Feinberg, V. Kuznetsov, D. Dimitrov, W. Paul, HIV infection: how effective is drug combination treatment? Immunol. Today 19 (11) (1998) 528.
56. Mittler J.E., Sulzer B., Neumann A.U., Perelson A.S. Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Math. Biosci. 152:1998;143.
57. McLean A., Nowak M.A. Comptition between zidovudine-sensitive and zidovudine-resistant strains of HIV. AIDS. 6(1):1992;71.
58. + T-cells during primary human immunodeficiency virus 1 infection Proc. Nat. Acad. Sci. USA. 95:1998;8869.
59. + T-cells provides a mechanism for lifelong persistence of human immunodeficiency virus 1 even in patients on effective combination therapy Nat. Med. 5(5):1999;512.
60. McLean A., Michie A.C. In vivo estimates of division and death rates of human T-lymphocytes. Proc. Nat. Acad. Sci. USA. 92:1995;3707.
61. D. Wick, Tap-and-drain versus general activation: steady-states and the AIDS paradox, preprint, 1999.
62. Kamata J.T., Mozaffarian A., Overbaugh J. J. Virol. 72(1):1998;245.
63. Zvi Grossman, M. Polis, M.B. Feinberg, Zehava Grossman, I. Levi, S. Jankelevich, R. Yarchoan, J. Boon, F. de Wolf, J.M.A. Lange, J. Goudsmit, D.S. Dimitrov, W.E. Paul, Attenuated decline of HIV infection under HAART, preprint, May 1999.
64. Ascher M.S., Sheppard H.W. AIDS as immune system activation: a model for pathogenesis. Clin. Exp. Immunol. 73:1988;165.
65. Pantaleo G., Fauci A.S. HIV-1 infection in the lymphoid organs: a model for disease development. J. NIH Res. 5:1993;68.
66. Freedman D. Approximating Countable Markov Chains. 1971;Holden-Day, San Francisco.
67. John F. Partial Differential Equations. 1971;Springer, New York.
68. W.H. Press, B.P. Flannery, S.A. Teukolsky, W.T. Vetterling, Numerical Recipes in C, section 15.2, Cambridge University, Cambridge, 1988.